CABG shows survival benefits in study of patients with diabetes, CAD

08/13/2013 | Healio

Data on 232 patients with diabetes and multivessel coronary artery disease indicated that those who underwent coronary artery bypass graft surgery had lower rates of cardiac and overall mortality at 10 years, compared with those who received medical therapy. Differences in mortality rates between percutaneous coronary intervention and both medical therapy and CABG were not statistically significant, researchers reported in the American Heart Journal.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA